Published in
Springer Verlag, PharmacoEconomics, 1(32), p. 1-4
DOI: 10.1007/s40273-013-0118-6
Links
Tools
Why Should Regulators Consider Using Patient Preferences in Benefit-risk Assessment?
Journal article published in 2013 by
Janine A. van Til 
,
Maarten J. Ijzerman
,
Maarten J. Ijzerman
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 